Neurogene Inc. <NGNE.O>: H.C. Wainwright cuts target price to $65 from $70
NGNE•Related News
Canada's Milestone Pharma misses Q2 product revenue expectations
MIST•
LeonaBio spotlights lasofoxifene at DAVA Oncology breast cancer summit
LONA•
Local Bounti Q2 revenue rises on higher production and sales
LOCL•
Marex Q2 FY26 profit after tax more than doubles to $155.3 million; revenue rises 39% to $695.8 million
MRX•
Ituran declares USD 0.5 per share Q2 dividend, totaling USD 10 million
ITRN•